Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04016571
What this trial is testing

Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Belfast Health and Social Care Trust 31
Testing effectiveness (Phase 2)Study completedNCT04194814
What this trial is testing

Skin bioMARkers for Atopic Eczema Therapy Evaluation

Who this might be right for
Atopic Eczema/Dermatitis (Non-Specific)
Sheffield Teaching Hospitals NHS Foundation Trust 37
Large-scale testing (Phase 3)Study completedNCT00457015
What this trial is testing

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 96
Not applicableLooking for participantsNCT05602376
What this trial is testing

Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging

Who this might be right for
HIV InfectionsMenTreatment Adherence
Desmond Tutu HIV Foundation 3,642
Testing effectiveness (Phase 2)Study completedNCT00593710
What this trial is testing

Losartan Versus Atenolol for the Treatment of Marfan Syndrome

Who this might be right for
Marfan Syndrome
University of British Columbia 17
Large-scale testing (Phase 3)Study completedNCT00984126
What this trial is testing

Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 214
Testing effectiveness (Phase 2)Ended earlyNCT04990440
What this trial is testing

Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 6
Not applicableStudy completedNCT02731040
What this trial is testing

Exome Sequencing for Atypical Femoral Fractures

Who this might be right for
Atypical Femoral FracturesOsteoporosisBisphosphonate Therapy
Washington University School of Medicine 38
Testing effectiveness (Phase 2)Study completedNCT00019097
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Stage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
National Cancer Institute (NCI)
Not applicableStudy completedNCT05488938
What this trial is testing

Intensive Anti-Scoliosis Postural Intervention for Individuals With Rett Syndrome Supported by a Smartphone Application

Who this might be right for
Rett Syndrome
Ariel University 20
Not applicableEnded earlyNCT00149318
What this trial is testing

Enzyme Replacement Therapy in Fabry Disease

Who this might be right for
Fabry Disease
Mario Negri Institute for Pharmacological Research 2
Not applicableStudy completedNCT00874926
What this trial is testing

EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

Who this might be right for
Hemophilia A
Bayer 405
Post-approval studies (Phase 4)Active Not RecruitingNCT05983068
What this trial is testing

Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Not applicableStudy completedNCT05951010
What this trial is testing

Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38

Who this might be right for
Spinocerebellar Ataxias
University of Cagliari 7
Not applicableStudy completedNCT04220918
What this trial is testing

Taste of Medicines in Children

Who this might be right for
Medication AdherenceMedication Reaction
Children's Hospital of Philadelphia 136
Testing effectiveness (Phase 2)Ended earlyNCT04524858
What this trial is testing

Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)

Who this might be right for
Cryopyrin-Associated Periodic Syndrome
Aclaris Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Study completedNCT00724048
What this trial is testing

Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease

Who this might be right for
Huntington Disease
Teva Branded Pharmaceutical Products R&D, Inc. 227
Post-approval studies (Phase 4)UnknownNCT03781050
What this trial is testing

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Who this might be right for
Peutz-Jeghers Syndrome
Peking Union Medical College Hospital 10
Large-scale testing (Phase 3)Study completedNCT03140449
What this trial is testing

Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

Who this might be right for
Facial Angiofibroma
National Taiwan University Hospital 52
Next Page